AMPCOVID-19: Evaluation of the Evolution of Pregnancies in the First Trimester Following MAR Management During a COVD-19 Pandemic Period

Sponsor

University Hospital, Strasbourg, France (Other)

Overall Status

Completed

CT.gov ID

NCT04415359

Collaborator

(none)

700

Enrollment

Location

Actual Duration (Months)

140.2

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Because of the physiological changes inherent in pregnancy, pregnant women with lower respiratory tract infections often have more worrisome outcomes compared to non-pregnant individuals, including a higher rate of hospital and intensive care unit admissions.

Condition or Disease	Intervention/Treatment	Phase
Covid-19

Study Design

Study Type:

Observational

Actual Enrollment :

700 participants

Observational Model:

Case-Only

Time Perspective:

Other

Official Title:

Evaluation of the Evolution of Pregnancies in the First Trimester Following a Medically Assisted Procreation (MAR) Management During a COVD-19 Pandemic Period

Actual Study Start Date :

Aug 1, 2020

Actual Primary Completion Date :

Oct 31, 2020

Actual Study Completion Date :

Dec 31, 2020

Outcome Measures

Primary Outcome Measures

Study of the evolution of pregnancies in the first trimester following MAR management during a COVD-19 pandemic period [12th week of Amenorrhea]

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 43 Years

Sexes Eligible for Study:

Female

Inclusion Criteria:

Patient included in a Medically Assisted Procreation (MAR) protocol aged between 18 and 43 years of age
Patient who has already signed a consent to management